Honored to receive the @ASCO Young Investigator Award from the @ConquerCancerFd to investigate the role of contemporary mortgage/housing discrimination in driving poor cancer care and outcomes. Thanks to my mentors @cepollack @DrNogueiraL @DrRobinYabroff & @Hopkins_HemOnc.

RT @RyanNipp: Food Insecurity, Housing Insecurity, and Transportation Barriers to Care Among #Cancer Survivors With Medical Financial Hards….

🧨 Slow news day? Here’s a PSA with purpose: ASCO Quality Care abstracts are due June 10. Got a trainee doing equity, policy, or QI work? Tell them to apply for a Merit Award (CV + LOR). It gives funding, visibility & momentum. Here’s how it helped me:.🔗

End-of-life disparities in lung cancer at #ASCO2025: Who dies at home vs hospital?. Dr Alamin (Chief Resident @UCF) from our policy team presents striking disparities in place of death for lung cancer patients across the US. Today: Poster Bd 50, 130-430PM | Hall A @ONealCancerUAB

Our oral presentation at #ASCO2025 today: environmental burden isn’t just a health hazard - it’s a cancer risk. Counties with higher pollution burden see more cancer, especially lung cancer. Calls for policy action to address environmental justice. @ONealCancerUAB @azar_mak

RT @crisbergerot: 🏥 Quality cancer care is more than treatment—it's environment, equity, time, and tech. Don't miss the #ASCO25 session on….

Lung cancer mortality at #ASCO2025: Are rural Americans left behind?. @DenaRhinehart (⭐️ Chief Fellow @Hopkins_HemOnc) from our policy team finds slower gains for younger adults & women. Come check out Poster Bd 387 | Today, 130-430PM | Hall A @ONealCancerUAB @ADesaiMD @GRocqueMD

Does political environment shape cancer survival in the US? 🗳️🇺🇸. Join @wyndobbs (PGY3, Hopkins) today from our policy team at #ASCO2025 to unpack this data. It’s not the politics - it’s the systems we need to fix. Poster Bd 370 | Today, 1:30-4:30PM | Hall A @ONealCancerUAB

We argue for 3 key actions:.1. Clinician & patient education.2. High-quality, multi-center research.3. Policy advocacy to ensure equitable access.Patients deserve better symptom relief while fighting cancer. Let’s treat the whole patient, not just the cancer.

Figure 1 in our paper illustrates barriers:.🚧 Limited research & clinician education.💰 High patient costs & patchy insurance coverage.🔄 The cycle of low adoption and poor evidence

We highlight the landscape of supportive care devices for cancer side effects—scalp cooling for alopecia, compression sleeves for lymphedema, cold gloves for neuropathy, & more (Table 1 in article). But evidence & access gaps remain!

Published today in @OncJournal: our commentary on the promise & pitfalls of supportive care devices in cancer. These can transform quality of life if we address barriers & push for better evidence & policy. @ONealCancerUAB. Led by Dr. Phung @UMNCancer. 📝

RT @fumikochino: 🚨@OncoAlert: . As we prepare for #ASCO25. don't forget that #ASCOQLTY25 abstracts are due 6/10/2025! This health service….

I didn’t go to @UofAlabama, but yesterday I toured the campus, met remarkable students, & gave a talk at my first event with the Blackburn Institute - a nonpartisan leadership society I was recently honored to be elected into for a 3 yr term to help build a stronger Alabama.

Today I was proud to represent Alabama as the sole delegate on Capitol Hill from @ASCO, advocating for consistent research funding, smarter prior auth policies & solutions to ongoing drug shortages. There’s still much work to do in Alabama and across the country @ONealCancerUAB

RT @fumikochino: The best part of @ASCO #ASCOAdvocacySummit is advocating on Capital Hill for patients with cancer. The 2nd best part is….

5/ Bottom line: PIN codes are a step forward, but barriers remain. Policymakers must refine them to ensure they truly expand access to care for those who need it most. Full article here:

4/ We also discuss challenges in implementation—like state-by-state variability in navigator training and uncertainty around telehealth reimbursement. More clarity is needed for these codes to work effectively.

3/ There’s a catch: PIN codes come with a 20% Medicare Part B copay (for e.g. $15 for a 30 min visit). Patients who need them most may struggle to afford them, raising concerns about access and equity. Will this limit their impact? Time will tell.

2/ PIN codes aim to help patients navigate complex health systems by reimbursing non-clinical navigators. Unlike older care management codes like CCM and PCM, they can be billed multiple times across providers—potentially improving care coordination.

Our latest in @JAMAOnc looks at one of the bigger changes in cancer care reimbursement in recent memory. Medicare’s new Principal Illness Navigation (PIN) codes could fundamentally reshape how we support patients w/ complex needs. Led by @wyndobbs Cc @SamyuktaMD @ONealCancerUAB